548 Episodo

  1. Late-Stage Trial Underway for Treatment of Rare Obesity Disorder

    Publicado: 12/12/2018
  2. RegenxBio Bets Its Gene Therapy Technology Provides Competitive Edge

    Publicado: 5/12/2018
  3. The Potential for Digital Health Technologies to Transform Clinical Trials

    Publicado: 28/11/2018
  4. Matching Volunteers to Rare Disease Organizations in Need

    Publicado: 21/11/2018
  5. How One Rare Disease Organization Used Technology to Provide Greater Patient Insight to FDA

    Publicado: 14/11/2018
  6. The Potentially Deadly Consequences of an Oversight in Newborn Screening Tests

    Publicado: 7/11/2018
  7. Advancing a New Approach to Sickle Cell Disease

    Publicado: 31/10/2018
  8. Conquering Life with a Rare Disease

    Publicado: 24/10/2018
  9. Why Rare Disease Drug Developers Need Regular Interaction with the FDA

    Publicado: 17/10/2018
  10. Making the Case for an FDA Rare Disease Center of Excellence

    Publicado: 10/10/2018
  11. An Elite Runner Makes a Cross-Canada Trek for His Son and Rare Disease

    Publicado: 3/10/2018
  12. How Rare Disease Advocates Can Get The Most out of Collaborations

    Publicado: 26/9/2018
  13. Establishing Clinical Standards for a Rare Disease

    Publicado: 19/9/2018
  14. Teen Rare Disease Advocate Fights the Condition That Took His Brother's Life

    Publicado: 12/9/2018
  15. Addressing the Emotional Toll of Rare Diseases

    Publicado: 5/9/2018
  16. Forging a Research Agenda for a Rare Disease

    Publicado: 29/8/2018
  17. Living with an Uncertain Rare Diagnosis

    Publicado: 22/8/2018
  18. A Rare Disease Advocate Teaches Doctors to See and Speak Differently

    Publicado: 17/8/2018
  19. The Caregiver Who Cried in the Shower

    Publicado: 8/8/2018
  20. Curating Patient Data to Accelerate Rare Disease Drug Development

    Publicado: 1/8/2018

18 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site